nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—EGFR—colon cancer	0.134	0.767	CbGaD
Docetaxel—breast cancer—colon cancer	0.0948	0.243	CtDrD
Docetaxel—stomach cancer—colon cancer	0.0818	0.209	CtDrD
Docetaxel—pancreatic cancer—colon cancer	0.0763	0.195	CtDrD
Docetaxel—ovarian cancer—colon cancer	0.0763	0.195	CtDrD
Docetaxel—lung cancer—colon cancer	0.0616	0.158	CtDrD
Docetaxel—ABCB1—colon cancer	0.0407	0.233	CbGaD
Docetaxel—TUBB8—Vincristine—colon cancer	0.023	0.0766	CbGbCtD
Docetaxel—TUBB6—Vincristine—colon cancer	0.023	0.0766	CbGbCtD
Docetaxel—TUBB2B—Vincristine—colon cancer	0.023	0.0766	CbGbCtD
Docetaxel—TUBB4A—Vincristine—colon cancer	0.023	0.0766	CbGbCtD
Docetaxel—TUBB3—Vincristine—colon cancer	0.023	0.0766	CbGbCtD
Docetaxel—TUBB2A—Vincristine—colon cancer	0.023	0.0766	CbGbCtD
Docetaxel—TUBB4B—Vincristine—colon cancer	0.0193	0.064	CbGbCtD
Docetaxel—TUBB1—Vincristine—colon cancer	0.0193	0.064	CbGbCtD
Docetaxel—TUBB—Vincristine—colon cancer	0.0193	0.064	CbGbCtD
Docetaxel—ABCC10—Vincristine—colon cancer	0.0147	0.0489	CbGbCtD
Docetaxel—ABCC10—Methotrexate—colon cancer	0.00892	0.0296	CbGbCtD
Docetaxel—SLC22A7—Fluorouracil—colon cancer	0.00795	0.0264	CbGbCtD
Docetaxel—ABCC1—Irinotecan—colon cancer	0.00651	0.0216	CbGbCtD
Docetaxel—ABCC1—Vincristine—colon cancer	0.00569	0.0189	CbGbCtD
Docetaxel—SLCO1B3—Methotrexate—colon cancer	0.00498	0.0165	CbGbCtD
Docetaxel—ABCC2—Irinotecan—colon cancer	0.00482	0.016	CbGbCtD
Docetaxel—SLC22A7—Methotrexate—colon cancer	0.00439	0.0146	CbGbCtD
Docetaxel—ABCG2—Irinotecan—colon cancer	0.00435	0.0145	CbGbCtD
Docetaxel—ABCC2—Vincristine—colon cancer	0.00421	0.014	CbGbCtD
Docetaxel—ABCG2—Fluorouracil—colon cancer	0.00418	0.0139	CbGbCtD
Docetaxel—ABCG2—Vincristine—colon cancer	0.00381	0.0126	CbGbCtD
Docetaxel—ABCC1—Methotrexate—colon cancer	0.00344	0.0114	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.00322	0.0107	CbGbCtD
Docetaxel—CYP3A7—Irinotecan—colon cancer	0.00322	0.0107	CbGbCtD
Docetaxel—CYP3A7—Vincristine—colon cancer	0.00281	0.00934	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.00281	0.00934	CbGbCtD
Docetaxel—ABCC2—Methotrexate—colon cancer	0.00255	0.00847	CbGbCtD
Docetaxel—CYP3A5—Irinotecan—colon cancer	0.00241	0.00801	CbGbCtD
Docetaxel—ABCG2—Methotrexate—colon cancer	0.0023	0.00765	CbGbCtD
Docetaxel—CYP3A5—Vincristine—colon cancer	0.00211	0.007	CbGbCtD
Docetaxel—ABCB1—Irinotecan—colon cancer	0.00157	0.00521	CbGbCtD
Docetaxel—ABCB1—Vincristine—colon cancer	0.00137	0.00456	CbGbCtD
Docetaxel—ABCC2—bile—colon cancer	0.00127	0.0477	CbGeAlD
Docetaxel—KIF11—embryo—colon cancer	0.00126	0.0475	CbGeAlD
Docetaxel—KIF11—Topotecan—Irinotecan—colon cancer	0.00105	0.763	CbGdCrCtD
Docetaxel—CYP3A4—Irinotecan—colon cancer	0.000941	0.00312	CbGbCtD
Docetaxel—ABCB1—Methotrexate—colon cancer	0.000831	0.00276	CbGbCtD
Docetaxel—CYP3A4—Vincristine—colon cancer	0.000822	0.00273	CbGbCtD
Docetaxel—KIF11—bone marrow—colon cancer	0.00072	0.0272	CbGeAlD
Docetaxel—KIF11—vagina—colon cancer	0.00069	0.026	CbGeAlD
Docetaxel—MAP4—embryo—colon cancer	0.00058	0.0219	CbGeAlD
Docetaxel—NR1I2—digestive system—colon cancer	0.00055	0.0208	CbGeAlD
Docetaxel—MAP2—embryo—colon cancer	0.000457	0.0172	CbGeAlD
Docetaxel—KIF11—lymph node—colon cancer	0.000446	0.0168	CbGeAlD
Docetaxel—MAP4—renal system—colon cancer	0.000439	0.0166	CbGeAlD
Docetaxel—BCL2—epithelium—colon cancer	0.00043	0.0162	CbGeAlD
Docetaxel—BCL2—smooth muscle tissue—colon cancer	0.000415	0.0156	CbGeAlD
Docetaxel—NR1I2—liver—colon cancer	0.00041	0.0155	CbGeAlD
Docetaxel—BCL2—renal system—colon cancer	0.000399	0.0151	CbGeAlD
Docetaxel—TUBB3—lymphoid tissue—colon cancer	0.000365	0.0138	CbGeAlD
Docetaxel—MAP4—lymphoid tissue—colon cancer	0.000365	0.0138	CbGeAlD
Docetaxel—MAP4—digestive system—colon cancer	0.00036	0.0136	CbGeAlD
Docetaxel—TUBB3—digestive system—colon cancer	0.00036	0.0136	CbGeAlD
Docetaxel—TUBB4A—embryo—colon cancer	0.000353	0.0133	CbGeAlD
Docetaxel—BCL2—lymphoid tissue—colon cancer	0.000331	0.0125	CbGeAlD
Docetaxel—BCL2—digestive system—colon cancer	0.000327	0.0124	CbGeAlD
Docetaxel—KIF11—Vinblastine—Vincristine—colon cancer	0.000325	0.237	CbGdCrCtD
Docetaxel—TUBB1—bone marrow—colon cancer	0.000325	0.0122	CbGeAlD
Docetaxel—MAP4—vagina—colon cancer	0.000318	0.012	CbGeAlD
Docetaxel—Cabazitaxel—ABCB1—colon cancer	0.000314	0.553	CrCbGaD
Docetaxel—BCL2—bone marrow—colon cancer	0.000302	0.0114	CbGeAlD
Docetaxel—SLC22A7—renal system—colon cancer	0.000299	0.0113	CbGeAlD
Docetaxel—MAP2—digestive system—colon cancer	0.000284	0.0107	CbGeAlD
Docetaxel—SLCO1B3—vagina—colon cancer	0.000278	0.0105	CbGeAlD
Docetaxel—TUBB4B—embryo—colon cancer	0.000275	0.0104	CbGeAlD
Docetaxel—MAP4—liver—colon cancer	0.000268	0.0101	CbGeAlD
Docetaxel—TUBB4A—renal system—colon cancer	0.000267	0.0101	CbGeAlD
Docetaxel—MAPT—lymph node—colon cancer	0.000262	0.00987	CbGeAlD
Docetaxel—TUBB6—epithelium—colon cancer	0.000258	0.00975	CbGeAlD
Docetaxel—TUBB2B—renal system—colon cancer	0.000258	0.00974	CbGeAlD
Docetaxel—TUBB—smooth muscle tissue—colon cancer	0.000254	0.00958	CbGeAlD
Docetaxel—Paclitaxel—ABCB1—colon cancer	0.000253	0.447	CrCbGaD
Docetaxel—TUBB2A—smooth muscle tissue—colon cancer	0.000252	0.00953	CbGeAlD
Docetaxel—MAP2—vagina—colon cancer	0.00025	0.00945	CbGeAlD
Docetaxel—TUBB6—smooth muscle tissue—colon cancer	0.000249	0.0094	CbGeAlD
Docetaxel—SLC22A7—digestive system—colon cancer	0.000245	0.00925	CbGeAlD
Docetaxel—EGFR—liver—colon cancer	0.000241	0.00909	CbGeAlD
Docetaxel—TUBB6—renal system—colon cancer	0.00024	0.00905	CbGeAlD
Docetaxel—SLCO1B3—liver—colon cancer	0.000235	0.00886	CbGeAlD
Docetaxel—TUBB4A—lymphoid tissue—colon cancer	0.000222	0.00837	CbGeAlD
Docetaxel—TUBB4A—digestive system—colon cancer	0.000219	0.00827	CbGeAlD
Docetaxel—TUBB4B—smooth muscle tissue—colon cancer	0.000216	0.00817	CbGeAlD
Docetaxel—TUBB2B—digestive system—colon cancer	0.000212	0.00799	CbGeAlD
Docetaxel—MAP2—liver—colon cancer	0.000211	0.00797	CbGeAlD
Docetaxel—ABCC10—renal system—colon cancer	0.00021	0.00792	CbGeAlD
Docetaxel—TUBB4B—renal system—colon cancer	0.000208	0.00786	CbGeAlD
Docetaxel—MAP4—lymph node—colon cancer	0.000206	0.00776	CbGeAlD
Docetaxel—TUBB2A—digestive system—colon cancer	0.000199	0.00752	CbGeAlD
Docetaxel—TUBB6—lymphoid tissue—colon cancer	0.000199	0.00751	CbGeAlD
Docetaxel—CYP3A7—liver—colon cancer	0.000198	0.00747	CbGeAlD
Docetaxel—TUBB6—digestive system—colon cancer	0.000197	0.00742	CbGeAlD
Docetaxel—TUBB2B—vagina—colon cancer	0.000187	0.00706	CbGeAlD
Docetaxel—BCL2—lymph node—colon cancer	0.000187	0.00705	CbGeAlD
Docetaxel—EGFR—lymph node—colon cancer	0.000185	0.00697	CbGeAlD
Docetaxel—TUBB—bone marrow—colon cancer	0.000185	0.00697	CbGeAlD
Docetaxel—TUBB2A—bone marrow—colon cancer	0.000184	0.00693	CbGeAlD
Docetaxel—SLC22A7—liver—colon cancer	0.000183	0.00689	CbGeAlD
Docetaxel—TUBB6—bone marrow—colon cancer	0.000181	0.00684	CbGeAlD
Docetaxel—TUBB—vagina—colon cancer	0.000177	0.00668	CbGeAlD
Docetaxel—TUBB2A—vagina—colon cancer	0.000176	0.00664	CbGeAlD
Docetaxel—ABCC10—lymphoid tissue—colon cancer	0.000174	0.00658	CbGeAlD
Docetaxel—TUBB6—vagina—colon cancer	0.000174	0.00655	CbGeAlD
Docetaxel—TUBB4B—lymphoid tissue—colon cancer	0.000173	0.00653	CbGeAlD
Docetaxel—ABCC10—digestive system—colon cancer	0.000172	0.0065	CbGeAlD
Docetaxel—CYP1B1—smooth muscle tissue—colon cancer	0.000171	0.00647	CbGeAlD
Docetaxel—TUBB4B—digestive system—colon cancer	0.000171	0.00645	CbGeAlD
Docetaxel—ABCC2—renal system—colon cancer	0.000169	0.00636	CbGeAlD
Docetaxel—CYP3A7-CYP3A51P—liver—colon cancer	0.000168	0.00635	CbGeAlD
Docetaxel—CYP1B1—renal system—colon cancer	0.000165	0.00623	CbGeAlD
Docetaxel—TUBB4A—liver—colon cancer	0.000163	0.00616	CbGeAlD
Docetaxel—MAP2—lymph node—colon cancer	0.000162	0.00611	CbGeAlD
Docetaxel—ABCC10—bone marrow—colon cancer	0.000159	0.00599	CbGeAlD
Docetaxel—TUBB4B—bone marrow—colon cancer	0.000158	0.00594	CbGeAlD
Docetaxel—ABCC10—vagina—colon cancer	0.000152	0.00574	CbGeAlD
Docetaxel—TUBB4B—vagina—colon cancer	0.000151	0.00569	CbGeAlD
Docetaxel—TUBB—liver—colon cancer	0.000149	0.00563	CbGeAlD
Docetaxel—TUBB2A—liver—colon cancer	0.000149	0.0056	CbGeAlD
Docetaxel—TUBB6—liver—colon cancer	0.000146	0.00553	CbGeAlD
Docetaxel—ABCC2—digestive system—colon cancer	0.000138	0.00522	CbGeAlD
Docetaxel—CYP1B1—lymphoid tissue—colon cancer	0.000137	0.00517	CbGeAlD
Docetaxel—CYP1B1—digestive system—colon cancer	0.000135	0.00511	CbGeAlD
Docetaxel—ABCB1—blood vessel—colon cancer	0.000134	0.00506	CbGeAlD
Docetaxel—ABCC10—liver—colon cancer	0.000128	0.00484	CbGeAlD
Docetaxel—TUBB4B—liver—colon cancer	0.000127	0.0048	CbGeAlD
Docetaxel—TUBB4A—lymph node—colon cancer	0.000125	0.00472	CbGeAlD
Docetaxel—TUBB2B—lymph node—colon cancer	0.000121	0.00456	CbGeAlD
Docetaxel—TUBB—lymph node—colon cancer	0.000114	0.00432	CbGeAlD
Docetaxel—CYP3A5—renal system—colon cancer	0.000114	0.0043	CbGeAlD
Docetaxel—TUBB2A—lymph node—colon cancer	0.000114	0.0043	CbGeAlD
Docetaxel—TUBB6—lymph node—colon cancer	0.000112	0.00424	CbGeAlD
Docetaxel—ABCC1—vagina—colon cancer	0.000108	0.00406	CbGeAlD
Docetaxel—ABCC2—liver—colon cancer	0.000103	0.00389	CbGeAlD
Docetaxel—CYP1B1—liver—colon cancer	0.000101	0.00381	CbGeAlD
Docetaxel—ABCC10—lymph node—colon cancer	9.83e-05	0.00371	CbGeAlD
Docetaxel—TUBB4B—lymph node—colon cancer	9.76e-05	0.00368	CbGeAlD
Docetaxel—CYP3A5—digestive system—colon cancer	9.36e-05	0.00353	CbGeAlD
Docetaxel—ABCG2—bone marrow—colon cancer	9.29e-05	0.00351	CbGeAlD
Docetaxel—ABCC1—liver—colon cancer	9.07e-05	0.00342	CbGeAlD
Docetaxel—ABCG2—vagina—colon cancer	8.9e-05	0.00336	CbGeAlD
Docetaxel—CYP3A4—renal system—colon cancer	8.56e-05	0.00323	CbGeAlD
Docetaxel—CYP3A5—vagina—colon cancer	8.26e-05	0.00312	CbGeAlD
Docetaxel—ABCB1—embryo—colon cancer	8.01e-05	0.00302	CbGeAlD
Docetaxel—ABCC2—lymph node—colon cancer	7.9e-05	0.00298	CbGeAlD
Docetaxel—CYP1B1—lymph node—colon cancer	7.73e-05	0.00292	CbGeAlD
Docetaxel—ABCG2—liver—colon cancer	7.51e-05	0.00283	CbGeAlD
Docetaxel—CYP3A4—digestive system—colon cancer	7.02e-05	0.00265	CbGeAlD
Docetaxel—CYP3A5—liver—colon cancer	6.97e-05	0.00263	CbGeAlD
Docetaxel—ABCC1—lymph node—colon cancer	6.96e-05	0.00262	CbGeAlD
Docetaxel—ABCB1—epithelium—colon cancer	6.53e-05	0.00247	CbGeAlD
Docetaxel—ABCB1—renal system—colon cancer	6.06e-05	0.00229	CbGeAlD
Docetaxel—ABCG2—lymph node—colon cancer	5.76e-05	0.00217	CbGeAlD
Docetaxel—CYP3A4—liver—colon cancer	5.23e-05	0.00197	CbGeAlD
Docetaxel—ABCB1—lymphoid tissue—colon cancer	5.03e-05	0.0019	CbGeAlD
Docetaxel—ABCB1—digestive system—colon cancer	4.97e-05	0.00188	CbGeAlD
Docetaxel—Lethargy—Methotrexate—colon cancer	4.78e-05	0.000711	CcSEcCtD
Docetaxel—Renal failure—Capecitabine—colon cancer	4.77e-05	0.000709	CcSEcCtD
Docetaxel—Myocardial infarction—Capecitabine—colon cancer	4.76e-05	0.000707	CcSEcCtD
Docetaxel—Neuropathy peripheral—Capecitabine—colon cancer	4.76e-05	0.000707	CcSEcCtD
Docetaxel—Anaphylactic shock—Vincristine—colon cancer	4.75e-05	0.000706	CcSEcCtD
Docetaxel—Oedema—Vincristine—colon cancer	4.75e-05	0.000706	CcSEcCtD
Docetaxel—Jaundice—Capecitabine—colon cancer	4.73e-05	0.000703	CcSEcCtD
Docetaxel—Stomatitis—Capecitabine—colon cancer	4.73e-05	0.000703	CcSEcCtD
Docetaxel—Infection—Vincristine—colon cancer	4.72e-05	0.000701	CcSEcCtD
Docetaxel—Conjunctivitis—Capecitabine—colon cancer	4.72e-05	0.000701	CcSEcCtD
Docetaxel—Convulsion—Fluorouracil—colon cancer	4.7e-05	0.000699	CcSEcCtD
Docetaxel—Confusional state—Irinotecan—colon cancer	4.66e-05	0.000693	CcSEcCtD
Docetaxel—Nervous system disorder—Vincristine—colon cancer	4.66e-05	0.000692	CcSEcCtD
Docetaxel—Thrombocytopenia—Vincristine—colon cancer	4.65e-05	0.000691	CcSEcCtD
Docetaxel—Anaphylactic shock—Irinotecan—colon cancer	4.62e-05	0.000687	CcSEcCtD
Docetaxel—Oedema—Irinotecan—colon cancer	4.62e-05	0.000687	CcSEcCtD
Docetaxel—Myalgia—Fluorouracil—colon cancer	4.62e-05	0.000687	CcSEcCtD
Docetaxel—Chest pain—Fluorouracil—colon cancer	4.62e-05	0.000687	CcSEcCtD
Docetaxel—Infection—Irinotecan—colon cancer	4.59e-05	0.000683	CcSEcCtD
Docetaxel—Hepatobiliary disease—Capecitabine—colon cancer	4.59e-05	0.000682	CcSEcCtD
Docetaxel—ABCB1—bone marrow—colon cancer	4.58e-05	0.00173	CbGeAlD
Docetaxel—Epistaxis—Capecitabine—colon cancer	4.58e-05	0.00068	CcSEcCtD
Docetaxel—Shock—Irinotecan—colon cancer	4.55e-05	0.000676	CcSEcCtD
Docetaxel—Nervous system disorder—Irinotecan—colon cancer	4.54e-05	0.000674	CcSEcCtD
Docetaxel—Agranulocytosis—Capecitabine—colon cancer	4.53e-05	0.000673	CcSEcCtD
Docetaxel—Thrombocytopenia—Irinotecan—colon cancer	4.53e-05	0.000673	CcSEcCtD
Docetaxel—Anorexia—Vincristine—colon cancer	4.53e-05	0.000673	CcSEcCtD
Docetaxel—Confusional state—Fluorouracil—colon cancer	4.47e-05	0.000664	CcSEcCtD
Docetaxel—Hypotension—Vincristine—colon cancer	4.44e-05	0.00066	CcSEcCtD
Docetaxel—Oedema—Fluorouracil—colon cancer	4.43e-05	0.000658	CcSEcCtD
Docetaxel—Anaphylactic shock—Fluorouracil—colon cancer	4.43e-05	0.000658	CcSEcCtD
Docetaxel—Anorexia—Irinotecan—colon cancer	4.41e-05	0.000655	CcSEcCtD
Docetaxel—Ataxia—Methotrexate—colon cancer	4.41e-05	0.000655	CcSEcCtD
Docetaxel—Infection—Fluorouracil—colon cancer	4.4e-05	0.000654	CcSEcCtD
Docetaxel—ABCB1—vagina—colon cancer	4.39e-05	0.00166	CbGeAlD
Docetaxel—Haemoglobin—Capecitabine—colon cancer	4.38e-05	0.000651	CcSEcCtD
Docetaxel—Rhinitis—Capecitabine—colon cancer	4.37e-05	0.000649	CcSEcCtD
Docetaxel—Hepatitis—Capecitabine—colon cancer	4.36e-05	0.000648	CcSEcCtD
Docetaxel—Haemorrhage—Capecitabine—colon cancer	4.36e-05	0.000648	CcSEcCtD
Docetaxel—Nervous system disorder—Fluorouracil—colon cancer	4.34e-05	0.000646	CcSEcCtD
Docetaxel—Thrombocytopenia—Fluorouracil—colon cancer	4.34e-05	0.000645	CcSEcCtD
Docetaxel—Hypoaesthesia—Capecitabine—colon cancer	4.33e-05	0.000644	CcSEcCtD
Docetaxel—Liver function test abnormal—Methotrexate—colon cancer	4.33e-05	0.000643	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Vincristine—colon cancer	4.33e-05	0.000643	CcSEcCtD
Docetaxel—Pharyngitis—Capecitabine—colon cancer	4.32e-05	0.000643	CcSEcCtD
Docetaxel—Tachycardia—Fluorouracil—colon cancer	4.32e-05	0.000643	CcSEcCtD
Docetaxel—Hypotension—Irinotecan—colon cancer	4.32e-05	0.000642	CcSEcCtD
Docetaxel—Urinary tract disorder—Capecitabine—colon cancer	4.3e-05	0.00064	CcSEcCtD
Docetaxel—Insomnia—Vincristine—colon cancer	4.29e-05	0.000638	CcSEcCtD
Docetaxel—Oedema peripheral—Capecitabine—colon cancer	4.29e-05	0.000638	CcSEcCtD
Docetaxel—Connective tissue disorder—Capecitabine—colon cancer	4.28e-05	0.000636	CcSEcCtD
Docetaxel—Urethral disorder—Capecitabine—colon cancer	4.27e-05	0.000635	CcSEcCtD
Docetaxel—Paraesthesia—Vincristine—colon cancer	4.26e-05	0.000634	CcSEcCtD
Docetaxel—Breast disorder—Methotrexate—colon cancer	4.24e-05	0.00063	CcSEcCtD
Docetaxel—Anorexia—Fluorouracil—colon cancer	4.22e-05	0.000628	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Methotrexate—colon cancer	4.22e-05	0.000628	CcSEcCtD
Docetaxel—Visual impairment—Capecitabine—colon cancer	4.2e-05	0.000624	CcSEcCtD
Docetaxel—Insomnia—Irinotecan—colon cancer	4.18e-05	0.000622	CcSEcCtD
Docetaxel—Paraesthesia—Irinotecan—colon cancer	4.15e-05	0.000617	CcSEcCtD
Docetaxel—Hypotension—Fluorouracil—colon cancer	4.14e-05	0.000615	CcSEcCtD
Docetaxel—Decreased appetite—Vincristine—colon cancer	4.13e-05	0.000614	CcSEcCtD
Docetaxel—Dyspnoea—Irinotecan—colon cancer	4.12e-05	0.000613	CcSEcCtD
Docetaxel—Erythema multiforme—Capecitabine—colon cancer	4.12e-05	0.000612	CcSEcCtD
Docetaxel—Somnolence—Irinotecan—colon cancer	4.11e-05	0.000611	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Vincristine—colon cancer	4.1e-05	0.000609	CcSEcCtD
Docetaxel—Fatigue—Vincristine—colon cancer	4.09e-05	0.000609	CcSEcCtD
Docetaxel—Eye disorder—Capecitabine—colon cancer	4.07e-05	0.000605	CcSEcCtD
Docetaxel—Dyspepsia—Irinotecan—colon cancer	4.07e-05	0.000605	CcSEcCtD
Docetaxel—Pain—Vincristine—colon cancer	4.06e-05	0.000604	CcSEcCtD
Docetaxel—Constipation—Vincristine—colon cancer	4.06e-05	0.000604	CcSEcCtD
Docetaxel—Cardiac disorder—Capecitabine—colon cancer	4.04e-05	0.000601	CcSEcCtD
Docetaxel—Flushing—Capecitabine—colon cancer	4.04e-05	0.000601	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Fluorouracil—colon cancer	4.04e-05	0.0006	CcSEcCtD
Docetaxel—Decreased appetite—Irinotecan—colon cancer	4.02e-05	0.000598	CcSEcCtD
Docetaxel—Insomnia—Fluorouracil—colon cancer	4.01e-05	0.000596	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Irinotecan—colon cancer	3.99e-05	0.000594	CcSEcCtD
Docetaxel—Fatigue—Irinotecan—colon cancer	3.99e-05	0.000593	CcSEcCtD
Docetaxel—Paraesthesia—Fluorouracil—colon cancer	3.98e-05	0.000591	CcSEcCtD
Docetaxel—Pain—Irinotecan—colon cancer	3.95e-05	0.000588	CcSEcCtD
Docetaxel—Constipation—Irinotecan—colon cancer	3.95e-05	0.000588	CcSEcCtD
Docetaxel—Angiopathy—Capecitabine—colon cancer	3.95e-05	0.000588	CcSEcCtD
Docetaxel—Dyspnoea—Fluorouracil—colon cancer	3.95e-05	0.000587	CcSEcCtD
Docetaxel—Somnolence—Fluorouracil—colon cancer	3.94e-05	0.000585	CcSEcCtD
Docetaxel—Immune system disorder—Capecitabine—colon cancer	3.93e-05	0.000585	CcSEcCtD
Docetaxel—Mediastinal disorder—Capecitabine—colon cancer	3.93e-05	0.000584	CcSEcCtD
Docetaxel—Chills—Capecitabine—colon cancer	3.91e-05	0.000581	CcSEcCtD
Docetaxel—Dyspepsia—Fluorouracil—colon cancer	3.9e-05	0.00058	CcSEcCtD
Docetaxel—Arrhythmia—Capecitabine—colon cancer	3.89e-05	0.000579	CcSEcCtD
Docetaxel—Gastrointestinal pain—Vincristine—colon cancer	3.88e-05	0.000577	CcSEcCtD
Docetaxel—Decreased appetite—Fluorouracil—colon cancer	3.85e-05	0.000572	CcSEcCtD
Docetaxel—Alopecia—Capecitabine—colon cancer	3.85e-05	0.000572	CcSEcCtD
Docetaxel—Pancytopenia—Methotrexate—colon cancer	3.85e-05	0.000572	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Fluorouracil—colon cancer	3.82e-05	0.000568	CcSEcCtD
Docetaxel—Mental disorder—Capecitabine—colon cancer	3.82e-05	0.000567	CcSEcCtD
Docetaxel—Feeling abnormal—Irinotecan—colon cancer	3.81e-05	0.000567	CcSEcCtD
Docetaxel—Erythema—Capecitabine—colon cancer	3.79e-05	0.000564	CcSEcCtD
Docetaxel—Malnutrition—Capecitabine—colon cancer	3.79e-05	0.000564	CcSEcCtD
Docetaxel—Neutropenia—Methotrexate—colon cancer	3.79e-05	0.000563	CcSEcCtD
Docetaxel—Pain—Fluorouracil—colon cancer	3.79e-05	0.000563	CcSEcCtD
Docetaxel—Gastrointestinal pain—Irinotecan—colon cancer	3.78e-05	0.000562	CcSEcCtD
Docetaxel—Body temperature increased—Vincristine—colon cancer	3.75e-05	0.000558	CcSEcCtD
Docetaxel—Abdominal pain—Vincristine—colon cancer	3.75e-05	0.000558	CcSEcCtD
Docetaxel—Dysgeusia—Capecitabine—colon cancer	3.71e-05	0.000552	CcSEcCtD
Docetaxel—ABCB1—liver—colon cancer	3.7e-05	0.0014	CbGeAlD
Docetaxel—Back pain—Capecitabine—colon cancer	3.67e-05	0.000545	CcSEcCtD
Docetaxel—Abdominal pain—Irinotecan—colon cancer	3.66e-05	0.000543	CcSEcCtD
Docetaxel—Body temperature increased—Irinotecan—colon cancer	3.66e-05	0.000543	CcSEcCtD
Docetaxel—Feeling abnormal—Fluorouracil—colon cancer	3.65e-05	0.000543	CcSEcCtD
Docetaxel—Muscle spasms—Capecitabine—colon cancer	3.65e-05	0.000542	CcSEcCtD
Docetaxel—Pneumonia—Methotrexate—colon cancer	3.63e-05	0.00054	CcSEcCtD
Docetaxel—Infestation NOS—Methotrexate—colon cancer	3.61e-05	0.000537	CcSEcCtD
Docetaxel—Infestation—Methotrexate—colon cancer	3.61e-05	0.000537	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Methotrexate—colon cancer	3.58e-05	0.000532	CcSEcCtD
Docetaxel—Renal failure—Methotrexate—colon cancer	3.55e-05	0.000528	CcSEcCtD
Docetaxel—Stomatitis—Methotrexate—colon cancer	3.52e-05	0.000524	CcSEcCtD
Docetaxel—Conjunctivitis—Methotrexate—colon cancer	3.51e-05	0.000522	CcSEcCtD
Docetaxel—Anaemia—Capecitabine—colon cancer	3.51e-05	0.000521	CcSEcCtD
Docetaxel—Body temperature increased—Fluorouracil—colon cancer	3.5e-05	0.000521	CcSEcCtD
Docetaxel—Hypersensitivity—Vincristine—colon cancer	3.5e-05	0.00052	CcSEcCtD
Docetaxel—Hepatobiliary disease—Methotrexate—colon cancer	3.42e-05	0.000508	CcSEcCtD
Docetaxel—Epistaxis—Methotrexate—colon cancer	3.41e-05	0.000507	CcSEcCtD
Docetaxel—Hypersensitivity—Irinotecan—colon cancer	3.41e-05	0.000507	CcSEcCtD
Docetaxel—Asthenia—Vincristine—colon cancer	3.41e-05	0.000506	CcSEcCtD
Docetaxel—Syncope—Capecitabine—colon cancer	3.4e-05	0.000506	CcSEcCtD
Docetaxel—Leukopenia—Capecitabine—colon cancer	3.39e-05	0.000505	CcSEcCtD
Docetaxel—Agranulocytosis—Methotrexate—colon cancer	3.37e-05	0.000501	CcSEcCtD
Docetaxel—Palpitations—Capecitabine—colon cancer	3.35e-05	0.000498	CcSEcCtD
Docetaxel—Loss of consciousness—Capecitabine—colon cancer	3.33e-05	0.000496	CcSEcCtD
Docetaxel—Asthenia—Irinotecan—colon cancer	3.32e-05	0.000493	CcSEcCtD
Docetaxel—Cough—Capecitabine—colon cancer	3.31e-05	0.000492	CcSEcCtD
Docetaxel—Hypertension—Capecitabine—colon cancer	3.27e-05	0.000487	CcSEcCtD
Docetaxel—Hypersensitivity—Fluorouracil—colon cancer	3.26e-05	0.000485	CcSEcCtD
Docetaxel—Haemoglobin—Methotrexate—colon cancer	3.26e-05	0.000485	CcSEcCtD
Docetaxel—Diarrhoea—Vincristine—colon cancer	3.25e-05	0.000483	CcSEcCtD
Docetaxel—Haemorrhage—Methotrexate—colon cancer	3.24e-05	0.000482	CcSEcCtD
Docetaxel—Hepatitis—Methotrexate—colon cancer	3.24e-05	0.000482	CcSEcCtD
Docetaxel—Chest pain—Capecitabine—colon cancer	3.23e-05	0.00048	CcSEcCtD
Docetaxel—Arthralgia—Capecitabine—colon cancer	3.23e-05	0.00048	CcSEcCtD
Docetaxel—Myalgia—Capecitabine—colon cancer	3.23e-05	0.00048	CcSEcCtD
Docetaxel—Pharyngitis—Methotrexate—colon cancer	3.22e-05	0.000479	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	3.21e-05	0.000477	CcSEcCtD
Docetaxel—Urinary tract disorder—Methotrexate—colon cancer	3.2e-05	0.000476	CcSEcCtD
Docetaxel—Urethral disorder—Methotrexate—colon cancer	3.18e-05	0.000473	CcSEcCtD
Docetaxel—Diarrhoea—Irinotecan—colon cancer	3.16e-05	0.00047	CcSEcCtD
Docetaxel—Dry mouth—Capecitabine—colon cancer	3.16e-05	0.000469	CcSEcCtD
Docetaxel—Dizziness—Vincristine—colon cancer	3.14e-05	0.000467	CcSEcCtD
Docetaxel—Pruritus—Fluorouracil—colon cancer	3.13e-05	0.000466	CcSEcCtD
Docetaxel—Visual impairment—Methotrexate—colon cancer	3.13e-05	0.000465	CcSEcCtD
Docetaxel—Confusional state—Capecitabine—colon cancer	3.12e-05	0.000464	CcSEcCtD
Docetaxel—Oedema—Capecitabine—colon cancer	3.1e-05	0.00046	CcSEcCtD
Docetaxel—Infection—Capecitabine—colon cancer	3.07e-05	0.000457	CcSEcCtD
Docetaxel—Erythema multiforme—Methotrexate—colon cancer	3.07e-05	0.000456	CcSEcCtD
Docetaxel—Dizziness—Irinotecan—colon cancer	3.06e-05	0.000455	CcSEcCtD
Docetaxel—Shock—Capecitabine—colon cancer	3.05e-05	0.000453	CcSEcCtD
Docetaxel—Nervous system disorder—Capecitabine—colon cancer	3.04e-05	0.000451	CcSEcCtD
Docetaxel—Eye disorder—Methotrexate—colon cancer	3.03e-05	0.000451	CcSEcCtD
Docetaxel—Diarrhoea—Fluorouracil—colon cancer	3.03e-05	0.000451	CcSEcCtD
Docetaxel—Thrombocytopenia—Capecitabine—colon cancer	3.03e-05	0.000451	CcSEcCtD
Docetaxel—Tachycardia—Capecitabine—colon cancer	3.02e-05	0.000449	CcSEcCtD
Docetaxel—Vomiting—Vincristine—colon cancer	3.02e-05	0.000449	CcSEcCtD
Docetaxel—Cardiac disorder—Methotrexate—colon cancer	3.01e-05	0.000447	CcSEcCtD
Docetaxel—Skin disorder—Capecitabine—colon cancer	3.01e-05	0.000447	CcSEcCtD
Docetaxel—Rash—Vincristine—colon cancer	2.99e-05	0.000445	CcSEcCtD
Docetaxel—Dermatitis—Vincristine—colon cancer	2.99e-05	0.000445	CcSEcCtD
Docetaxel—Headache—Vincristine—colon cancer	2.97e-05	0.000442	CcSEcCtD
Docetaxel—Anorexia—Capecitabine—colon cancer	2.95e-05	0.000439	CcSEcCtD
Docetaxel—Angiopathy—Methotrexate—colon cancer	2.94e-05	0.000437	CcSEcCtD
Docetaxel—Vomiting—Irinotecan—colon cancer	2.94e-05	0.000437	CcSEcCtD
Docetaxel—Immune system disorder—Methotrexate—colon cancer	2.93e-05	0.000435	CcSEcCtD
Docetaxel—Dizziness—Fluorouracil—colon cancer	2.93e-05	0.000435	CcSEcCtD
Docetaxel—Mediastinal disorder—Methotrexate—colon cancer	2.92e-05	0.000435	CcSEcCtD
Docetaxel—Rash—Irinotecan—colon cancer	2.92e-05	0.000433	CcSEcCtD
Docetaxel—Dermatitis—Irinotecan—colon cancer	2.91e-05	0.000433	CcSEcCtD
Docetaxel—Chills—Methotrexate—colon cancer	2.91e-05	0.000433	CcSEcCtD
Docetaxel—Headache—Irinotecan—colon cancer	2.9e-05	0.000431	CcSEcCtD
Docetaxel—Hypotension—Capecitabine—colon cancer	2.89e-05	0.00043	CcSEcCtD
Docetaxel—Alopecia—Methotrexate—colon cancer	2.87e-05	0.000426	CcSEcCtD
Docetaxel—Mental disorder—Methotrexate—colon cancer	2.84e-05	0.000422	CcSEcCtD
Docetaxel—ABCB1—lymph node—colon cancer	2.84e-05	0.00107	CbGeAlD
Docetaxel—Erythema—Methotrexate—colon cancer	2.82e-05	0.00042	CcSEcCtD
Docetaxel—Malnutrition—Methotrexate—colon cancer	2.82e-05	0.00042	CcSEcCtD
Docetaxel—Nausea—Vincristine—colon cancer	2.82e-05	0.000419	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Capecitabine—colon cancer	2.82e-05	0.000419	CcSEcCtD
Docetaxel—Vomiting—Fluorouracil—colon cancer	2.82e-05	0.000419	CcSEcCtD
Docetaxel—Insomnia—Capecitabine—colon cancer	2.8e-05	0.000416	CcSEcCtD
Docetaxel—Rash—Fluorouracil—colon cancer	2.79e-05	0.000415	CcSEcCtD
Docetaxel—Dermatitis—Fluorouracil—colon cancer	2.79e-05	0.000415	CcSEcCtD
Docetaxel—Paraesthesia—Capecitabine—colon cancer	2.78e-05	0.000413	CcSEcCtD
Docetaxel—Headache—Fluorouracil—colon cancer	2.77e-05	0.000412	CcSEcCtD
Docetaxel—Dysgeusia—Methotrexate—colon cancer	2.76e-05	0.000411	CcSEcCtD
Docetaxel—Dyspnoea—Capecitabine—colon cancer	2.76e-05	0.00041	CcSEcCtD
Docetaxel—Nausea—Irinotecan—colon cancer	2.75e-05	0.000408	CcSEcCtD
Docetaxel—Back pain—Methotrexate—colon cancer	2.73e-05	0.000406	CcSEcCtD
Docetaxel—Dyspepsia—Capecitabine—colon cancer	2.72e-05	0.000405	CcSEcCtD
Docetaxel—Decreased appetite—Capecitabine—colon cancer	2.69e-05	0.0004	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Capecitabine—colon cancer	2.67e-05	0.000397	CcSEcCtD
Docetaxel—Fatigue—Capecitabine—colon cancer	2.67e-05	0.000397	CcSEcCtD
Docetaxel—Pain—Capecitabine—colon cancer	2.65e-05	0.000393	CcSEcCtD
Docetaxel—Constipation—Capecitabine—colon cancer	2.65e-05	0.000393	CcSEcCtD
Docetaxel—Nausea—Fluorouracil—colon cancer	2.63e-05	0.000391	CcSEcCtD
Docetaxel—Anaemia—Methotrexate—colon cancer	2.61e-05	0.000388	CcSEcCtD
Docetaxel—Feeling abnormal—Capecitabine—colon cancer	2.55e-05	0.000379	CcSEcCtD
Docetaxel—Gastrointestinal pain—Capecitabine—colon cancer	2.53e-05	0.000376	CcSEcCtD
Docetaxel—Leukopenia—Methotrexate—colon cancer	2.53e-05	0.000376	CcSEcCtD
Docetaxel—Cough—Methotrexate—colon cancer	2.46e-05	0.000366	CcSEcCtD
Docetaxel—Abdominal pain—Capecitabine—colon cancer	2.45e-05	0.000364	CcSEcCtD
Docetaxel—Body temperature increased—Capecitabine—colon cancer	2.45e-05	0.000364	CcSEcCtD
Docetaxel—Convulsion—Methotrexate—colon cancer	2.45e-05	0.000364	CcSEcCtD
Docetaxel—Myalgia—Methotrexate—colon cancer	2.4e-05	0.000357	CcSEcCtD
Docetaxel—Chest pain—Methotrexate—colon cancer	2.4e-05	0.000357	CcSEcCtD
Docetaxel—Arthralgia—Methotrexate—colon cancer	2.4e-05	0.000357	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	2.39e-05	0.000355	CcSEcCtD
Docetaxel—Confusional state—Methotrexate—colon cancer	2.32e-05	0.000345	CcSEcCtD
Docetaxel—Anaphylactic shock—Methotrexate—colon cancer	2.3e-05	0.000343	CcSEcCtD
Docetaxel—Infection—Methotrexate—colon cancer	2.29e-05	0.00034	CcSEcCtD
Docetaxel—Hypersensitivity—Capecitabine—colon cancer	2.28e-05	0.000339	CcSEcCtD
Docetaxel—Nervous system disorder—Methotrexate—colon cancer	2.26e-05	0.000336	CcSEcCtD
Docetaxel—Thrombocytopenia—Methotrexate—colon cancer	2.26e-05	0.000335	CcSEcCtD
Docetaxel—Skin disorder—Methotrexate—colon cancer	2.24e-05	0.000333	CcSEcCtD
Docetaxel—Asthenia—Capecitabine—colon cancer	2.22e-05	0.00033	CcSEcCtD
Docetaxel—Anorexia—Methotrexate—colon cancer	2.2e-05	0.000327	CcSEcCtD
Docetaxel—Pruritus—Capecitabine—colon cancer	2.19e-05	0.000326	CcSEcCtD
Docetaxel—Hypotension—Methotrexate—colon cancer	2.15e-05	0.00032	CcSEcCtD
Docetaxel—Diarrhoea—Capecitabine—colon cancer	2.12e-05	0.000315	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Methotrexate—colon cancer	2.1e-05	0.000312	CcSEcCtD
Docetaxel—Insomnia—Methotrexate—colon cancer	2.08e-05	0.00031	CcSEcCtD
Docetaxel—Paraesthesia—Methotrexate—colon cancer	2.07e-05	0.000308	CcSEcCtD
Docetaxel—Dyspnoea—Methotrexate—colon cancer	2.05e-05	0.000305	CcSEcCtD
Docetaxel—Somnolence—Methotrexate—colon cancer	2.05e-05	0.000305	CcSEcCtD
Docetaxel—Dizziness—Capecitabine—colon cancer	2.05e-05	0.000304	CcSEcCtD
Docetaxel—Dyspepsia—Methotrexate—colon cancer	2.03e-05	0.000302	CcSEcCtD
Docetaxel—Decreased appetite—Methotrexate—colon cancer	2e-05	0.000298	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Methotrexate—colon cancer	1.99e-05	0.000296	CcSEcCtD
Docetaxel—Fatigue—Methotrexate—colon cancer	1.99e-05	0.000295	CcSEcCtD
Docetaxel—Pain—Methotrexate—colon cancer	1.97e-05	0.000293	CcSEcCtD
Docetaxel—Vomiting—Capecitabine—colon cancer	1.97e-05	0.000293	CcSEcCtD
Docetaxel—Rash—Capecitabine—colon cancer	1.95e-05	0.00029	CcSEcCtD
Docetaxel—Dermatitis—Capecitabine—colon cancer	1.95e-05	0.00029	CcSEcCtD
Docetaxel—Headache—Capecitabine—colon cancer	1.94e-05	0.000288	CcSEcCtD
Docetaxel—Feeling abnormal—Methotrexate—colon cancer	1.9e-05	0.000282	CcSEcCtD
Docetaxel—Gastrointestinal pain—Methotrexate—colon cancer	1.88e-05	0.00028	CcSEcCtD
Docetaxel—Nausea—Capecitabine—colon cancer	1.84e-05	0.000273	CcSEcCtD
Docetaxel—Abdominal pain—Methotrexate—colon cancer	1.82e-05	0.000271	CcSEcCtD
Docetaxel—Body temperature increased—Methotrexate—colon cancer	1.82e-05	0.000271	CcSEcCtD
Docetaxel—Hypersensitivity—Methotrexate—colon cancer	1.7e-05	0.000252	CcSEcCtD
Docetaxel—Asthenia—Methotrexate—colon cancer	1.65e-05	0.000246	CcSEcCtD
Docetaxel—Pruritus—Methotrexate—colon cancer	1.63e-05	0.000242	CcSEcCtD
Docetaxel—Diarrhoea—Methotrexate—colon cancer	1.58e-05	0.000234	CcSEcCtD
Docetaxel—Dizziness—Methotrexate—colon cancer	1.52e-05	0.000227	CcSEcCtD
Docetaxel—Vomiting—Methotrexate—colon cancer	1.46e-05	0.000218	CcSEcCtD
Docetaxel—Rash—Methotrexate—colon cancer	1.45e-05	0.000216	CcSEcCtD
Docetaxel—Dermatitis—Methotrexate—colon cancer	1.45e-05	0.000216	CcSEcCtD
Docetaxel—Headache—Methotrexate—colon cancer	1.44e-05	0.000215	CcSEcCtD
Docetaxel—Nausea—Methotrexate—colon cancer	1.37e-05	0.000203	CcSEcCtD
Docetaxel—EGFR—Developmental Biology—PPARG—colon cancer	6.64e-06	0.000174	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—HRAS—colon cancer	6.64e-06	0.000174	CbGpPWpGaD
Docetaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	6.63e-06	0.000174	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—FGFR3—colon cancer	6.62e-06	0.000174	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—HRAS—colon cancer	6.61e-06	0.000173	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—CTNNB1—colon cancer	6.55e-06	0.000172	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—SRC—colon cancer	6.54e-06	0.000172	CbGpPWpGaD
Docetaxel—BCL2—Immune System—FGFR3—colon cancer	6.52e-06	0.000171	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—MYC—colon cancer	6.51e-06	0.000171	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—EP300—colon cancer	6.49e-06	0.00017	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—PIK3CA—colon cancer	6.47e-06	0.00017	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—AKT1—colon cancer	6.44e-06	0.000169	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—AKT1—colon cancer	6.41e-06	0.000168	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—AKT1—colon cancer	6.41e-06	0.000168	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—KRAS—colon cancer	6.41e-06	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—HRAS—colon cancer	6.39e-06	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—AKT1—colon cancer	6.38e-06	0.000167	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—MYC—colon cancer	6.37e-06	0.000167	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—FGFR3—colon cancer	6.36e-06	0.000167	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—AKT1—colon cancer	6.34e-06	0.000166	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—SRC—colon cancer	6.31e-06	0.000166	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—colon cancer	6.31e-06	0.000166	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—NRAS—colon cancer	6.29e-06	0.000165	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.29e-06	0.000165	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—HRAS—colon cancer	6.26e-06	0.000164	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—colon cancer	6.25e-06	0.000164	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—colon cancer	6.25e-06	0.000164	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—AKT1—colon cancer	6.22e-06	0.000163	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.09e-06	0.00016	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—NRAS—colon cancer	6.07e-06	0.000159	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—CTNNB1—colon cancer	5.99e-06	0.000157	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—colon cancer	5.99e-06	0.000157	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—AKT1—colon cancer	5.97e-06	0.000157	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—colon cancer	5.97e-06	0.000157	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—AKT1—colon cancer	5.97e-06	0.000157	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—SRC—colon cancer	5.92e-06	0.000155	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—AKT1—colon cancer	5.92e-06	0.000155	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—PIK3CA—colon cancer	5.89e-06	0.000154	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—AKT1—colon cancer	5.86e-06	0.000154	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—AKT1—colon cancer	5.84e-06	0.000153	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.82e-06	0.000153	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—MYC—colon cancer	5.82e-06	0.000153	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—colon cancer	5.79e-06	0.000152	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—VEGFA—colon cancer	5.77e-06	0.000151	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ABCB1—colon cancer	5.7e-06	0.000149	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—NRAS—colon cancer	5.7e-06	0.000149	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—colon cancer	5.69e-06	0.000149	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	5.64e-06	0.000148	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—AKT1—colon cancer	5.64e-06	0.000148	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	5.62e-06	0.000147	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—TYMS—colon cancer	5.6e-06	0.000147	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—EGFR—colon cancer	5.53e-06	0.000145	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—AKT1—colon cancer	5.52e-06	0.000145	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CDH1—colon cancer	5.51e-06	0.000145	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HRAS—colon cancer	5.45e-06	0.000143	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—KRAS—colon cancer	5.42e-06	0.000142	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CDH1—colon cancer	5.37e-06	0.000141	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—colon cancer	5.29e-06	0.000139	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	5.24e-06	0.000137	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—colon cancer	5.23e-06	0.000137	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—KRAS—colon cancer	5.23e-06	0.000137	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—MYC—colon cancer	5.21e-06	0.000137	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	5.1e-06	0.000134	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	5.05e-06	0.000132	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—PIK3CA—colon cancer	4.98e-06	0.000131	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.95e-06	0.00013	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	4.93e-06	0.000129	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—KRAS—colon cancer	4.9e-06	0.000129	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—AKT1—colon cancer	4.81e-06	0.000126	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—PIK3CA—colon cancer	4.8e-06	0.000126	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.79e-06	0.000126	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—colon cancer	4.78e-06	0.000125	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD8A—colon cancer	4.71e-06	0.000124	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	4.69e-06	0.000123	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—CTNNB1—colon cancer	4.68e-06	0.000123	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—HRAS—colon cancer	4.61e-06	0.000121	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	4.56e-06	0.00012	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CHST5—colon cancer	4.47e-06	0.000117	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ODC1—colon cancer	4.47e-06	0.000117	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	4.44e-06	0.000117	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—HRAS—colon cancer	4.44e-06	0.000117	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—EP300—colon cancer	4.35e-06	0.000114	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.31e-06	0.000113	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—SRC—colon cancer	4.23e-06	0.000111	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—HRAS—colon cancer	4.17e-06	0.000109	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CTNNB1—colon cancer	4.13e-06	0.000108	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.12e-06	0.000108	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—VEGFA—colon cancer	4.12e-06	0.000108	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	4.09e-06	0.000107	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	4.08e-06	0.000107	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CTNNB1—colon cancer	4.07e-06	0.000107	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—AKT1—colon cancer	4.07e-06	0.000107	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—NRAS—colon cancer	4.07e-06	0.000107	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CDKN1A—colon cancer	4.03e-06	0.000106	CbGpPWpGaD
Docetaxel—EGFR—Immune System—BCL2L1—colon cancer	4.03e-06	0.000106	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ABCB1—colon cancer	4.03e-06	0.000106	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	4e-06	0.000105	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.98e-06	0.000104	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CDKN1A—colon cancer	3.97e-06	0.000104	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PPARG—colon cancer	3.96e-06	0.000104	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—TYMS—colon cancer	3.96e-06	0.000104	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—AKT1—colon cancer	3.92e-06	0.000103	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ABCB1—colon cancer	3.9e-06	0.000102	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CDKN1A—colon cancer	3.87e-06	0.000102	CbGpPWpGaD
Docetaxel—EGFR—Immune System—FGFR3—colon cancer	3.86e-06	0.000101	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—EP300—colon cancer	3.84e-06	0.000101	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—TYMS—colon cancer	3.83e-06	0.0001	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EP300—colon cancer	3.78e-06	9.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TGFB1—colon cancer	3.78e-06	9.91e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	3.78e-06	9.91e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—FGFR3—colon cancer	3.78e-06	9.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—SRC—colon cancer	3.73e-06	9.79e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—SRC—colon cancer	3.68e-06	9.65e-05	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—AKT1—colon cancer	3.61e-06	9.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—NRAS—colon cancer	3.59e-06	9.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—SRC—colon cancer	3.58e-06	9.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—FGFR3—colon cancer	3.56e-06	9.34e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ABCB1—colon cancer	3.54e-06	9.3e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—NRAS—colon cancer	3.54e-06	9.28e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ABCB1—colon cancer	3.51e-06	9.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—KRAS—colon cancer	3.5e-06	9.18e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—TYMS—colon cancer	3.48e-06	9.13e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	3.47e-06	9.1e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—APC—colon cancer	3.47e-06	9.1e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—TYMS—colon cancer	3.45e-06	9.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—NRAS—colon cancer	3.45e-06	9.04e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	3.36e-06	8.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—APC—colon cancer	3.27e-06	8.57e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—BRAF—colon cancer	3.26e-06	8.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDH1—colon cancer	3.26e-06	8.55e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EGFR—colon cancer	3.22e-06	8.45e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTGS2—colon cancer	3.12e-06	8.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KRAS—colon cancer	3.09e-06	8.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—BRAF—colon cancer	3.07e-06	8.06e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.05e-06	7.99e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KRAS—colon cancer	3.04e-06	7.99e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—colon cancer	2.97e-06	7.8e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KRAS—colon cancer	2.97e-06	7.78e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.95e-06	7.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PIK3CA—colon cancer	2.84e-06	7.45e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	2.83e-06	7.44e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PPARG—colon cancer	2.8e-06	7.35e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PIK3CA—colon cancer	2.8e-06	7.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PIK3CA—colon cancer	2.73e-06	7.15e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PPARG—colon cancer	2.71e-06	7.11e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTGS2—colon cancer	2.63e-06	6.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—colon cancer	2.63e-06	6.89e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—colon cancer	2.63e-06	6.89e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—EP300—colon cancer	2.59e-06	6.8e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—colon cancer	2.59e-06	6.79e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ABCB1—colon cancer	2.54e-06	6.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—colon cancer	2.52e-06	6.62e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TYMS—colon cancer	2.49e-06	6.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGFR3—colon cancer	2.49e-06	6.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—colon cancer	2.48e-06	6.51e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PPARG—colon cancer	2.47e-06	6.47e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PPARG—colon cancer	2.44e-06	6.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTNNB1—colon cancer	2.4e-06	6.31e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CTNNB1—colon cancer	2.36e-06	6.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDKN1A—colon cancer	2.35e-06	6.16e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—colon cancer	2.32e-06	6.08e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN1A—colon cancer	2.3e-06	6.04e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APC—colon cancer	2.29e-06	6e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—NRAS—colon cancer	2.29e-06	6e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—colon cancer	2.28e-06	5.99e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—EP300—colon cancer	2.24e-06	5.86e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—colon cancer	2.23e-06	5.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CTNNB1—colon cancer	2.22e-06	5.82e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—colon cancer	2.2e-06	5.78e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EP300—colon cancer	2.19e-06	5.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—SRC—colon cancer	2.17e-06	5.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN1A—colon cancer	2.17e-06	5.69e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—BRAF—colon cancer	2.15e-06	5.64e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—colon cancer	2.13e-06	5.59e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SRC—colon cancer	2.13e-06	5.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NRAS—colon cancer	2.09e-06	5.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—EP300—colon cancer	2.06e-06	5.41e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NRAS—colon cancer	2.05e-06	5.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—SRC—colon cancer	2.01e-06	5.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—colon cancer	1.97e-06	5.17e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—colon cancer	1.94e-06	5.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NRAS—colon cancer	1.93e-06	5.06e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—colon cancer	1.92e-06	5.04e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CA—colon cancer	1.92e-06	5.03e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MYC—colon cancer	1.91e-06	5.01e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TGFB1—colon cancer	1.9e-06	4.99e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TYMS—colon cancer	1.88e-06	4.94e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—colon cancer	1.87e-06	4.9e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—EP300—colon cancer	1.83e-06	4.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CA—colon cancer	1.81e-06	4.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—colon cancer	1.8e-06	4.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MYC—colon cancer	1.8e-06	4.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TGFB1—colon cancer	1.79e-06	4.71e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—EP300—colon cancer	1.77e-06	4.65e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARG—colon cancer	1.77e-06	4.64e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—colon cancer	1.76e-06	4.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—colon cancer	1.67e-06	4.39e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—colon cancer	1.66e-06	4.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CA—colon cancer	1.65e-06	4.34e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CA—colon cancer	1.62e-06	4.25e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—EP300—colon cancer	1.61e-06	4.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CASP3—colon cancer	1.61e-06	4.23e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—EP300—colon cancer	1.6e-06	4.2e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCND1—colon cancer	1.57e-06	4.12e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—colon cancer	1.57e-06	4.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CTNNB1—colon cancer	1.55e-06	4.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—colon cancer	1.53e-06	4.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CA—colon cancer	1.53e-06	4e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN1A—colon cancer	1.52e-06	3.98e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—colon cancer	1.5e-06	3.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—colon cancer	1.48e-06	3.88e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EP300—colon cancer	1.45e-06	3.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—colon cancer	1.41e-06	3.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SRC—colon cancer	1.41e-06	3.69e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—colon cancer	1.39e-06	3.65e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—colon cancer	1.37e-06	3.59e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CA—colon cancer	1.36e-06	3.56e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NRAS—colon cancer	1.35e-06	3.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—colon cancer	1.35e-06	3.54e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARG—colon cancer	1.33e-06	3.5e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—colon cancer	1.32e-06	3.47e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CA—colon cancer	1.31e-06	3.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MYC—colon cancer	1.26e-06	3.3e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TGFB1—colon cancer	1.26e-06	3.3e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—colon cancer	1.25e-06	3.27e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CA—colon cancer	1.19e-06	3.13e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CA—colon cancer	1.18e-06	3.1e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ABCB1—colon cancer	1.18e-06	3.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—colon cancer	1.16e-06	3.05e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TYMS—colon cancer	1.16e-06	3.04e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—EP300—colon cancer	1.16e-06	3.03e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—colon cancer	1.11e-06	2.91e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—colon cancer	1.07e-06	2.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CA—colon cancer	1.07e-06	2.8e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—colon cancer	1.05e-06	2.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—colon cancer	1.03e-06	2.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—colon cancer	9.89e-07	2.59e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—colon cancer	9.75e-07	2.56e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—colon cancer	9.67e-07	2.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—colon cancer	8.73e-07	2.29e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—EP300—colon cancer	8.72e-07	2.29e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CA—colon cancer	8.55e-07	2.24e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARG—colon cancer	8.22e-07	2.16e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—colon cancer	6.99e-07	1.83e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—colon cancer	6.46e-07	1.7e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CA—colon cancer	6.45e-07	1.69e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—EP300—colon cancer	5.37e-07	1.41e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—colon cancer	5.27e-07	1.38e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CA—colon cancer	3.98e-07	1.04e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—colon cancer	3.25e-07	8.52e-06	CbGpPWpGaD
